Judge dismisses Lousiana's Rezulin suit

Hear that sigh of relief from Pfizer? A New York judge tossed out a lawsuit pitting the State of Louisiana against Pfizer over the diabetes drug Rezulin, which was pulled from the market in 2000 because of liver toxicity problems.

Louisiana was trying to recover Medicaid payments for the drug and the costs of treating illnesses Rezulin caused. And it's only one of many lawsuits filed in the wake of the drug's withdrawal. Pfizer acquired the lawsuits in its buyout of Warner-Lambert; it settled many of the personal injury claims in 2003.

- see the Trading Markets report

Related Articles:
Supreme Court to hear Pfizer liability case. Report
A look inside Pfizer's biotech center. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.